Atlas Trials

Supratentorial Glioblastoma

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Supratentorial Glioblastoma

RecordFirmDate
LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma (NCT04479241)Istari Oncology, Inc.2020-10-21
Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma (NCT04105374)NRG Oncology2020-01-31
Prognostic Impact of Surgical Resection Extent for Supratentorial High Grade Gliomas. (NCT03997136)Assiut University2019-09-01
18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma (NCT03732352)Jonsson Comprehensive Cancer Center2018-11-28
Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma (NCT03197506)Mayo Clinic2018-01-15
Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma (NCT02311920)National Cancer Institute (NCI)2015-04-16
Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy (NCT01430351)M.D. Anderson Cancer Center2011-09-14
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma (NCT00884741)National Cancer Institute (NCI)2009-04-15

Track Supratentorial Glioblastoma automatically

Every clearance here is in the API, with alerts when new ones post.